Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4117311000202118 | Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4117321000202114 | Glecaprevir 50 mg and pibrentasvir 20 mg oral granules sachet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Is a | Product containing only glecaprevir and pibrentasvir in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has manufactured dose form | Oral granules | true | Inferred relationship | Some | ||
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has unit of presentation | Sachet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Plays role | Antiviral therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has precise active ingredient | Pibrentasvir (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has basis of strength substance (attribute) | Pibrentasvir (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has precise active ingredient | Glecaprevir (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has basis of strength substance (attribute) | Glecaprevir (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely glecaprevir 50 milligram and pibrentasvir 20 milligram/1 sachet conventional release oral granules (clinical drug) | Has presentation strength denominator unit (attribute) | Sachet (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR